3 ms·
Those free samples very much make treatment less affordable. They don’t need to hand out samples when their treatment is the only option, they need to advertise
by Retric 5y ago
Those free samples very much make treatment less affordable. They don’t need to hand out samples when their treatment is the only option, they need to advertise to out compete generics.
It’s shockingly effective, look at say prescriptions for patented opioids vs the vast numbers of equally effective generics. Doctors are extremely susceptible to advertising just like most people, the difference is it’s not their money being spent.
- emodendroket 5y agoIn the case of doctors it's more high-touch than plain old ads anyway. The representative stops by and chats them up, maybe they get some sponsored continuing education (which is of course designed to push expensive products), etc.
- catawbasam 5y agoAnd the reps are often smoking hot, so docs don't mind making a bit of time for conversation.
- geoduck14 5y agoFun fact: Female secretaries (or other "gatekeepers") are less likely to let hot female sales people back to the doctor.
- refurb 5y agoHuh? Per unit dispensing of generic opioids dwarfs branded opioids.
- Retric 5y ago“Clinical studies comparing the response and side effects of various opioids have not been able to show robust differences between drugs.” So, it’s not a question of which is prescribed more, it’s a question of why branded opioids are ever prescribed. We aren’t talking about a ~100 Billion dollars of accidental waste, it took a lot of work to extract that from the general public.
- refurb 5y agoI mean the biggest opioid sales were OxyContin and the argument there was the time release which wasn’t available in a generic. As a part of my job I’ve talked to insurance companies and they aren’t willing to pay for branded pain relief drugs unless there is some differentiating value.
- Retric 5y agohttps://www.fda.gov/drugs/information-drug-class/timeline-selected-fda-activities-and-significant-events-addressing-opioid-misuse-and-abuse https://www.fda.gov/drugs/information-drug-class/timeline-se... 1987 “May: MS Contin, (morphine sulfate) approved; first formulation of an opioid pain medicine that allowed dosing every 12 hours instead of every 4 to 6 hours.” 1990 “August: Duragesic (fentanyl transdermal system) approved; first formulation of an opioid pain medicine in a patch (sometimes referred to as a “skin patch”) that is changed every 3 days.” 1995 “December: OxyContin (oxycodone controlled-release) approved; first formulation of oxycodone that allowed dosing every 12 hours instead of every 4 to 6 hours.”